122252-45-3 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
2,4(1H,3H)-Pyrimidinedione, 5-nitro-1-(phenylmethyl)is used as a building block for the synthesis of other organic compounds, contributing to the development of new pharmaceutical agents. Its unique structural features and potential pharmacological properties make it a promising candidate for drug design and discovery.
Used in Medicinal Chemistry:
2,4(1H,3H)-Pyrimidinedione, 5-nitro-1-(phenylmethyl)is used as a target for drug design and discovery, with its nitro group making it a valuable synthetic intermediate. 2,4(1H,3H)-Pyrimidinedione, 5-nitro-1-(phenylmethyl)has the potential to be developed into novel pharmaceutical agents with potential anti-inflammatory, anticancer, or antimicrobial activities.
Used in Organic Synthesis:
2,4(1H,3H)-Pyrimidinedione, 5-nitro-1-(phenylmethyl)is used as a synthetic intermediate in the preparation of other organic compounds, facilitating the synthesis of complex molecules with potential applications in various fields, including pharmaceuticals and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 122252-45-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,2,5 and 2 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 122252-45:
(8*1)+(7*2)+(6*2)+(5*2)+(4*5)+(3*2)+(2*4)+(1*5)=83
83 % 10 = 3
So 122252-45-3 is a valid CAS Registry Number.
122252-45-3Relevant academic research and scientific papers
1-(2,4-Dinitrophenyl)-5-nitrouracil a versatile reagent for the synthesis of N1-modified uracil derivatives
Gondela,Sroka,Walczak
, p. 2143 - 2149 (2008/09/18)
1-(2,4-Dinitrophenyl)-5-nitrouracil has been used as a substrate in reactions with a number of compounds possessing primary amino groups such as: amino alcohols, aminodiols, esters of amino acids and benzylamines. As a result of regioselective course of p
Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
-
, (2008/06/13)
The invention relates to substituted polycyclic aryl and heteroaryl uracil compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
